Management of Bilateral Metachronous Adrenal Metastases from Hepatocellular Carcinoma
Overview
Overview
Journal
J Gastrointest Cancer
Publisher
Springer
Specialties
Gastroenterology
Oncology
Oncology
Date
2022 Aug 2
PMID
35917104
Authors
Authors
Affiliations
Affiliations
Soon will be listed here.
References
1.
Sung H, Ferlay J, Siegel R, Laversanne M, Soerjomataram I, Jemal A
. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin. 2021; 71(3):209-249.
DOI: 10.3322/caac.21660.
View
2.
Machairas N, Tsilimigras D, Pawlik T
. State-of-the-art surgery for hepatocellular carcinoma. Langenbecks Arch Surg. 2021; 406(7):2151-2162.
DOI: 10.1007/s00423-021-02298-3.
View
3.
Tsilimigras D, Moris D, Hyer J, Bagante F, Ratti F, Marques H
. Serum α-Fetoprotein Levels at Time of Recurrence Predict Post-Recurrence Outcomes Following Resection of Hepatocellular Carcinoma. Ann Surg Oncol. 2021; 28(12):7673-7683.
DOI: 10.1245/s10434-021-09977-x.
View
4.
Schlageter M, Quagliata L, Matter M, Perrina V, Tornillo L, Terracciano L
. Clinicopathological Features and Metastatic Pattern of Hepatocellular Carcinoma: An Autopsy Study of 398 Patients. Pathobiology. 2016; 83(6):301-7.
DOI: 10.1159/000446245.
View
5.
Uka K, Aikata H, Takaki S, Shirakawa H, Jeong S, Yamashina K
. Clinical features and prognosis of patients with extrahepatic metastases from hepatocellular carcinoma. World J Gastroenterol. 2007; 13(3):414-20.
PMC: 4065897.
DOI: 10.3748/wjg.v13.i3.414.
View